Results 191 to 200 of about 212,546 (262)
Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study. [PDF]
Yan C +8 more
europepmc +1 more source
Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia. [PDF]
Yang Y +14 more
europepmc +1 more source
Abstract Prostate cancer (PCa) is the second most common type of neoplasm, currently treated with a variety of therapeutic agents. Although advances in treatment over the past decade have improved overall survival, patients with advanced PCa eventually progress from hormone‐sensitive PCa to metastatic castration‐resistant PCa.
Giuseppe Schepisi +8 more
wiley +1 more source
Single cell transcriptional evolution of myeloid leukemia of Down syndrome. [PDF]
Trinh MK +24 more
europepmc +1 more source
ABSTRACT Sickle cell disease (SCD) affects millions worldwide but has limited treatment options, most of which carry significant side effects. At present, the only curative treatment for SCD is allogeneic or gene‐modified autologous hematopoietic stem cell (HSC) transplantation (Tx).
Oluwaseun O. Babatunde +4 more
wiley +1 more source
A case report of BCR-ABL(+) acute myeloid leukemia and literature review. [PDF]
Li J, Zheng W, Dong X, Wang J, Liu K.
europepmc +1 more source
ABSTRACT Objectives Partial gene duplications (PGDups) are a significant contributor to genetic disease. The precise genomic location and structure of PGDups are often unresolved using conventional methods, so prenatal diagnosis for PGDups is challenging, especially without ultrasound abnormalities.
Shengfang Qin +10 more
wiley +1 more source
Real-life data of patients with chronic myeloid leukemia in Amazonas. [PDF]
Abreu RS +12 more
europepmc +1 more source

